<DOC>
	<DOCNO>NCT02565602</DOCNO>
	<brief_summary>This study aim : 1 ) quantitatively assess parameter bone calcium balance healthy postmenopausal Asian woman Chinese descent ; 2 ) ass possible ethnic difference calcium metabolism direct comparison acquire data Chinese postmenopausal woman acquire early Caucasian postmenopausal woman use methodology ; 3 ) ass difference calcium strontium metabolism parallel evaluate strontium stable isotope use trace bone calcium metabolism qualitatively</brief_summary>
	<brief_title>Comparison Calcium Metabolism Caucasian Asian Postmenopausal Women Chinese Descent Use Strontium Qualitative Marker Calcium Metabolism</brief_title>
	<detailed_description>The study follow closely protocol use previously PI ETH Zurich study calcium metabolism healthy postmenopausal woman . Calcium metabolism study single oral administration calcium tracer ( Ca-41 ) follow excretion tracer urine 6 month . Obtained data use assess parameter calcium metabolism ( flux rate size body calcium compartment ) kinetic modelling . A strontium tracer ( Sr-84 ) administer parallel urinary excretion pattern compare Ca-41 excretion determine strontium tracer use assess calcium metabolism qualitatively . Subjects supplement Vit D throughout study . Vit D supplementation commence 1 month isotope administration .</detailed_description>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Cholecalciferol</mesh_term>
	<mesh_term>Calcium , Dietary</mesh_term>
	<criteria>1 . Last menstrual bleeding least 5 year ago . 2 . Between age 50 75 year old . 3 . Both parent 4 grandparent are/were Chinese descent . It necessity participant , participant 's parent grandparent 's born raise Singapore participate study . 4 . BMI 16 30 1 . Diagnosed osteoporosis 2 . Presence significant liver disease , malignancy ( exclude myeloma study group ) , malabsorption syndrome , hypoparathyroidism , hyperparathyroidism , sarcoidosis hyperthyroidism ( toxic multinodular goitre Graves disease ) , Paget 's disease osteosarcoma , acromegaly , Cushing 's syndrome , hypopituitarism , diabetes mellitus severe chronic obstructive pulmonary disease . 3 . Current smoking alcohol intake exceed one standard drink per day 4 . Undergoing treatment follow drug ( within last 12 month ) ) adrenocorticoid steroid ( 3 month long anytime &gt; 10 day treatment within previous 12 month ) ii ) anticonvulsant therapy iii ) pharmacological dos thyroid hormone ( cause decline TSH normal ) iv ) bisphosphonates v ) calcitonin vi ) synthetic parathyroid hormone vii ) selective estrogen receptor modulators viii ) strontium ranelate ix ) estrogen therapy x ) chemotherapeutic agent xi ) sodium fluoride ( history treatment fluoride ) xii ) medication know affect calcium metabolism ( diuretic , antacid , calcium channel blocker etc. ) . 5 . Presence chronic illness . 6 . Any significant medical , psychiatric and/or social issue determine investigator would compromise subject 's safety and/or compliance trial procedure . 7 . Any clinically significant screen laboratory abnormality ( determined investigator ) .</criteria>
	<gender>Female</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Calcium metabolism</keyword>
	<keyword>Osteoporosis</keyword>
	<keyword>Postmenopausal woman</keyword>
</DOC>